|
CN101098856A
|
|
Lactam compounds and their use as pharmaceuticals
|
|
CN1968698A
|
|
Piperazinylpiperidine derivatives as chemokine receptor antagonists
|
|
CN1774246A
|
|
Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases
|
|
EP1456187A1
|
|
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
|
|
EP1421061A1
|
|
Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
|
|
CA2453833A1
|
|
Tnf receptor 2 related protein variant
|
|
CA2453985A1
|
|
Receptors and membrane-associated proteins
|
|
CA2447662A1
|
|
Transporters and ion channels
|
|
CA2448116A1
|
|
Molecules for disease detection and treatment
|
|
CA2446023A1
|
|
Cell adhesion and extracellular matrix proteins
|
|
CA2445366A1
|
|
Molecules for disease detection and treatment
|
|
CA2444675A1
|
|
Secreted proteins
|
|
CA2443244A1
|
|
Enzymes
|
|
CA2442064A1
|
|
G-protein coupled receptors
|
|
AU2002254171A2
|
|
RXR activating molecules
|
|
CA2438235A1
|
|
Neurotransmission-associated proteins
|
|
CA2438215A1
|
|
Putative human enzymes
|
|
CA2437398A1
|
|
Molecules for disease detection and treatment
|
|
CA2437571A1
|
|
Receptors and membrane-associated proteins
|
|
CA2437185A1
|
|
Timm8b-related protein
|
